OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Fourth Frontier has achieved a crucial milestone with the FDA's clearance of the Frontier X Plus, a single-lead ECG monitor. Positioned to enhance heart health monitoring, this wearable device ...

Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the ...

Adding an extra hour every week of physical activity may lower the chance of developing the most common type of irregular heartbeat (arrythmia) by 11 percent, a new study shows.

A brisk walk or even housecleaning might help folks at risk lower their odds for the dangerous heart arrhythmia known ...

Professor Allan Lawrie discusses the future of personalised cardiovascular disease detection and monitoring and wearable ...

Atrial fibrillation (AF) often remains undiagnosed and independently ... adults screening for undiagnosed atrial AF using a 14-day electrocardiographic (ECG) monitor to reduce stroke. They conducted ...

Exposure to extreme heat may double or triple the risk of irregular heart rhythms in people with implanted defibrillators, ...

Heffron notes that in the sole earlier study that used activity monitors to investigate atrial fibrillation, researchers ...